about
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiologyGenetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G proteinRespiratory viruses other than influenza virus: impact and therapeutic advancesPhenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA virusesUse of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.Targeting MicroRNA Function in Respiratory Diseases: Mini-ReviewPotential Antiviral Agents from Marine Fungi: An OverviewSocial, economic, and health impact of the respiratory syncytial virus: a systematic searchSynthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideRole of oxidative stress on diesel-enhanced influenza infection in micePathophysiology of viral-induced exacerbations of COPDRSV-specific anti-viral immunity is disrupted by chronic ethanol consumptionRespiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial CulturesClinical characterization of influenza A and human respiratory syncytial virus among patients with influenza like illness.Mortality attributable to pandemic influenza A (H1N1) 2009 in San Luis Potosí, Mexico.Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year.Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infectionStructural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complexSurveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System.Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter monthsHospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997-2012Antiviral natural products and herbal medicines.Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness.Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responsesReal-time detection of virus particles and viral protein expression with two-color nanoparticle probes.Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.Immune responses and disease enhancement during respiratory syncytial virus infectionInhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymeraseModification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced ageRFI-641, a potent respiratory syncytial virus inhibitor.Molecular epidemiology of respiratory syncytial virus.New insights for development of a safe and protective RSV vaccinePharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model.Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cellsIdentification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
P2860
Q21133803-8C2D23BA-8A68-4FFB-A173-9F6382BD99C7Q24531958-E56F0F9D-A4C1-4B65-9D48-1EA26F773285Q24655957-73D4E82A-A6A9-4E57-B560-BF5E2E306B14Q24797827-3DEA8A14-AFBA-4E10-8785-BC15F35E7DF8Q24815873-CD18225E-A9E7-4A25-BAD3-3A983353ECCCQ26766476-457B81F2-B531-4E96-8DC2-2BE5686B1236Q26800107-532EEDB7-6DD9-448B-B46E-DD559E8852ACQ26852865-60B9ACA5-1F5F-4C16-AE80-BEACDF743874Q28067143-24362C6E-FD5D-4222-87C0-581643725227Q28067306-C32E549A-A199-447E-924A-453FDC6BB5B6Q28385200-80FE8FD6-352D-4B0C-BCC3-077B9511E5FBQ28389402-0CA9DFDF-FA44-41D4-BC7D-9DA3079AB407Q28394949-CC1E8224-A78E-4E29-B398-A1D792DD4F20Q28551477-039225AE-0232-4DBE-B0D8-A1A5DEBDDBE2Q30389641-CFE1BFFE-A283-4B14-BCFC-E45025D5F44CQ30399490-F8D10F51-61C9-4F1B-99C9-EC3DFE01F762Q30427052-CF7B2013-D0DA-45E2-AC5A-7194785027C8Q30436432-C888DD28-DC58-4A25-AEF6-E3E9429D43ABQ30580524-0A260A2A-0259-4975-8AA4-6C412E1BC227Q30821133-1DF28221-A066-43CE-8401-C5DDF4BD243EQ33234270-94128E02-4F5D-4D4A-AEA6-3AB67BDA0758Q33596559-86A7FDFD-82D5-4FF7-B02B-C1565D34E7C3Q33629343-FF0B96BA-D4F0-4CB1-BF48-D70154E32EB6Q33657624-E1CF03C4-66D8-4C81-967A-63CDDBEEBED8Q33684340-927C9C3B-5724-4CE0-ABD5-37B31C79CC2AQ33760691-D2C3120F-9736-4A42-9150-C02A13309E7DQ33812212-E73D12A1-7725-4963-8A71-42EA67975F30Q33843360-D84E5ACF-BC92-4642-B302-F263D24CEBC5Q33847030-96556340-5B4D-4D8F-8B0C-9A2F7AEE1CCCQ33937152-C0F734F3-07E5-42D8-99F1-637B9EBABF97Q34045568-D64A9574-00D7-4A2D-8090-481D19FAE6C0Q34059404-F85A7CCD-A584-49A5-B7AB-E765BC344F8DQ34059447-2EBC4E72-9EB9-45B6-A757-428C48A0ABEEQ34113730-44243399-FE8E-445D-826C-DBB61F36C0D5Q34191801-D1943D05-32A7-4C9D-9CDD-9D1DD5DBBC8FQ34249859-642E78A4-0D32-432F-8A59-57F8F3A25DDFQ34290125-9B21E985-F7D2-4CCE-B927-544C41DE52BDQ34391467-8FB3215B-63A1-43BD-BA1F-683FE412624AQ34465367-BB245AC7-DD77-41F5-9FFF-651B71DEFA96Q34504791-BBEBA6E1-FEC9-4A13-B579-5208E8319D2D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Respiratory syncytial virus infection in adults
@ast
Respiratory syncytial virus infection in adults
@en
type
label
Respiratory syncytial virus infection in adults
@ast
Respiratory syncytial virus infection in adults
@en
prefLabel
Respiratory syncytial virus infection in adults
@ast
Respiratory syncytial virus infection in adults
@en
P2860
P1476
Respiratory syncytial virus infection in adults
@en
P2093
P2860
P304
P356
10.1128/CMR.13.3.371-384.2000
P407
P577
2000-07-01T00:00:00Z